Research output per year
Research output per year
Personal profile
Headline
ASSOCIATE PROFESSOR | Medicine, Hematology and Medical Oncology
Fingerprint
Dive into the research topics where Keren Osman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A Randomized Trial of Mesenchymal Stromal Cells for Moderate to Severe Acute Respiratory Distress Syndrome from COVID-19
Bowdish, M. E., Barkauskas, C. E., Overbey, J. R., Gottlieb, R. L., Osman, K., Duggal, A., Marks, M. E., Hupf, J., Fernandes, E., Leshnower, B. G., Golob, J. L., Iribarne, A., Rassias, A. J., Moquete, E. G., O'Sullivan, K., Chang, H. L., Williams, J. B., Parnia, S., Patel, N. C., Desai, N. D., & 17 others, 1 Feb 2023, In: American Journal of Respiratory and Critical Care Medicine. 207, 3, p. 261-270 10 p.Research output: Contribution to journal › Article › peer-review
7 Scopus citations -
Real-world evidence of the safety and survival with CD19 CAR-T cell therapy for relapsed/refractory solid organ transplant-related PTLD
McKenna, M., Epperla, N., Ghobadi, A., Liu, J., Lazaryan, A., Ibrahim, U., Jacobson, C. A., Naik, S. G., Nastoupil, L., Chowdhury, S. M., Voorhees, T. J., Jacobs, MT., Farooq, U., Osman, K., Olszewski, A. J., Ahmed, S. & Evens, A. M., 2023, (Accepted/In press) In: British Journal of Haematology.Research output: Contribution to journal › Article › peer-review
Open Access -
Mesenchymal stromal cell therapy for acute respiratory distress syndrome due to coronavirus disease 2019
Whittaker Brown, S. A., Iancu-Rubin, C., Aboelela, A., Abrahams, A., Burke, E., Drummond, T., Grossman, F., Itescu, S., Lagdameo, J., Lin, J. Y., Mark, A., Levine, J. E. & Osman, K., Aug 2022, In: Cytotherapy. 24, 8, p. 835-840 6 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma
Elsawy, M., Chavez, J. C., Avivi, I., Larouche, J. F., Wannesson, L., Cwynarski, K., Osman, K., Davison, K., Rudzki, J. D., Dahiya, S., Dorritie, K., Jaglowski, S., Radford, J., Morschhauser, F., Cunningham, D., Martin Garcia-Sancho, A., Tzachanis, D., Ulrickson, M. L., Karmali, R., Kekre, N., & 11 others, 24 Nov 2022, In: Blood. 140, 21, p. 2248-2260 13 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
Phase 1/2 study of ixazomib with cyclophosphamide and dexamethasone in newly diagnosed AL amyloidosis
Rosenbaum, C. A., Özbek, U., Sanchez, L., Lagdameo, J., Abrahams, A., Hassoun, H., Lahoud, O., Niesvizky, R., Landau, H. J. & Osman, K., 27 Sep 2022, In: Blood advances. 6, 18, p. 5436-5439 4 p.Research output: Contribution to journal › Letter › peer-review
Open Access
Press/Media
-
What Factors Influence Hematological Recovery in Patients Who Receive CAR-T Therapies?
24/04/20 → 27/04/20
2 items of Media coverage
Press/Media
-
Planned Clinical Trial of Allogeneic Stem Cell Therapy Remestemcel-L in Patients with COVID-19
Keren Osman, John Levine & Annetine Gelijns
20/04/20
1 item of Media coverage
Press/Media
-
Mount Sinai Leading the Way in Innovative Stem Cell Therapy for COVID-19 Patients
Alan Moskowitz, Emilia Bagiella, Keren Osman, John Levine & Annetine Gelijns
10/04/20
3 items of Media coverage
Press/Media
-
Mount Sinai Health System Leading the Way in Innovative Stem Cell Therapy for COVID-19 Patients
Alan Moskowitz, Emilia Bagiella, Keren Osman, John Levine & Annetine Gelijns
10/04/20
1 item of Media coverage
Press/Media
-